Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
Stephen R. Smalley(Mayo Clinic), John S. Macdonald(Salford Royal NHS Foundation Trust), Stephen K. Williamson(The University of Kansas Cancer Center), Al B. Benson(Northwestern University), Robert J. Mayer(Applied Natural Sciences), Cynthia G. Leichman(NYU Langone Health), C. Cripps(Canadian Partnership Against Cancer), Tracy Maher(University of Illinois Chicago), John Pedersen(University of Illinois Chicago), Norman Estes(Southern Research Institute), Barbara Fisher(University of Illinois Chicago), James A. Martenson(Mayo Clinic), Phillip Periman(University of Illinois Chicago), Jacqueline Benedetti(University of Illinois Chicago), James N. Atkins(Southeastern Medical Oncology Center), John W. Kugler(Mayo Clinic), John M. Robertson(Beaumont Hospital, Royal Oak), Daniel G. Haller(University of Pennsylvania), Tyvin A. Rich(The University of Texas MD Anderson Cancer Center), Michael Tanaka(University of Illinois Chicago)
Cited by 167
Related Papers
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k